| Issue |
Section |
Title |
File |
| Vol 78, No 6 (2003) |
Editorial article |
Intradialysis hypotension: causes and sequelae |
|
| Vol 79, No 9 (2004) |
Editorial article |
Cardioprotective effect of erythropoietin preparations in patients with chronic renal failure |
|
| Vol 81, No 8 (2009) |
Editorial article |
The role of balanced low-protein diet in inhibition of progression of predialysis chronic disease of the kidneys in systemic diseases |
|
| Vol 82, No 6 (2010) |
Editorial article |
Mechanisms of phosphorus and calcium homeostatic disorders in the development of cardiovascular events in patients with chronic renal diseases. The role of fibroblast growth factor 23 and Klotho |
|
| Vol 83, No 6 (2011) |
Editorial article |
The role of D2 vitamin metabolite paricalcitol in nephroprotective strategy in chronic disease of the kidneys |
|
| Vol 84, No 6 (2012) |
Editorial article |
LONG-ACTING ERYTHROPOETIN EFFICACY IN THE TREATMENT OF NEPHROGENIC ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE AT A PREDIALYSIS STAGE |
|
| Vol 87, No 6 (2015) |
Editorial article |
Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease |
|
| Vol 88, No 4 (2016) |
Editorial article |
The serum level of the morphogenetic protein fibroblast growth factor 23 (FGF-23) as a marker for the efficiency of hyperphosphatemia therapy with phosphate-binding agents in chronic kidney disease |
(Rus)
|
| Vol 88, No 6 (2016) |
Editorial article |
Impact of anemia correction on the production of the circulating morphogenetic protein α-Klotho in patients with Stages 3B—4 chronic kidney disease: A new direction of cardionephroprotection |
(Rus)
|
| Vol 88, No 6 (2016) |
Editorial article |
Difficulties in correcting hyperphosphatemia in patients with chronic renal failure. A place of noncalcium-containing phosphate-binding drugs |
(Rus)
|
| Vol 90, No 6 (2018) |
Editorial article |
Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration |
(Rus)
|
| Vol 90, No 6 (2018) |
Editorial article |
Quality of life of chronic kidney disease patients on renal replacement therapy |
(Rus)
|
